bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

EURONEXT:BIM

bioMérieux S.A.

Last Close

96.80

26/07 15:35

Market Cap

10.94B

Beta: 0.12

Volume Today

55.50K

Avg: 124.93K

PE Ratio

54.18

PFCF: 126.53

Dividend Yield

0.84%

Payout:22.97%

Filings Not Available